FIELD: medicine.
SUBSTANCE: invention relates to medicine and veterinary and is intended for the acceleration of stopping bleeding in case of injury to blood vessels in traumas and wounds. A haemostatic agent contains 3-20 wt % of a polysaccharide, where the polysaccharide is represented by chitosan and/or starch, 0.1-2 wt % of calcium chloride and a 0.5-5% water solution of succinic or hydrochloric acid - the remaining part.
EFFECT: accelerating the initiation of the thrombus-forming process and enhancement of the regenerative ability of tissues in the area of wounds of different aetiology.
1 tbl, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HAEMOSTATIC PREPARATION | 2007 |
|
RU2333002C1 |
| LOCAL HEMOSTATIC POWDERY AGENT | 2017 |
|
RU2659139C1 |
| HEMOSTATIC GEL FOR SINGLE TOPICAL APPLICATION | 2023 |
|
RU2796161C1 |
| SINGLE TOPICAL APPLICATION HEMOSTATIC GEL MANUFACTURING METHOD | 2022 |
|
RU2789581C1 |
| HAEMOSTATIC AGENT BASED ON POLYVINYLPYRROLIDONE AND METHODS FOR PREPARING ITS PHARMACOLOGICAL FORMS | 2018 |
|
RU2705812C1 |
| HAEMOSTATIC AGENT BASED ON CHITOSAN SUCCINATE AND CALENDULA EXTRACT | 2019 |
|
RU2694372C1 |
| LOCAL HEMOSTATIC MEDICATION | 2009 |
|
RU2414225C1 |
| FLUID HEMOSTATIC AGENT | 2023 |
|
RU2805923C1 |
| LOCAL HEMOSTATIC AGENT | 2013 |
|
RU2519220C1 |
| HEMOSTATIC COATING IN FORM OF SPONGE OR FILM (VERSIONS) | 2016 |
|
RU2639379C1 |
